Literature DB >> 20372074

The involvement of Fyn kinase in resumption of the first meiotic division in mouse oocytes.

Mattan Levi1, Bernard Maro, Ruth Shalgi.   

Abstract

The process of resumption of the first meiotic division (RMI) in mammalian oocytes includes germinal vesicle breakdown (GVBD), spindle formation during first metaphase (MI), segregation of homologous chromosomes, extrusion of the first polar body (PBI) and an arrest at metaphase of the second meiotic division (MII). Previous studies suggest a role for Fyn, a non-receptor Src family tyrosine kinase, in the exit from MII arrest. In the current study we characterized the involvement of Fyn in RMI. Western blot analysis demonstrated a significant, proteasome independent, degradation of Fyn during GVBD. Immunostaining of fixed oocytes and confocal imaging of live oocytes microinjected with Fyn complementary RNA (cRNA) demonstrated Fyn localization to the oocyte cortex and to the spindle poles. Fyn was recruited during telophase to the cortical area surrounding the midzone of the spindle and was then translocated to the contractile ring during extrusion of PBI. GVBD, exit from MI and PBI extrusion were inhibited in oocytes exposed to the chemical inhibitor SU6656 or microinjected with dominant negative Fyn cRNA. None of the microinjected oocytes showed misaligned or lagging chromosomes during chromosomes segregation and the spindle migration and anchoring were not affected. However, the extruded PBI was of large size. Altogether, a role for Fyn in regulating several key pathways during the first meiotic division in mammalian oocytes is suggested, particularly at the GV and metaphase checkpoints and in signaling the ingression of the cleavage furrow.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372074     DOI: 10.4161/cc.9.8.11299

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

Review 1.  Src family kinases and paclitaxel sensitivity.

Authors:  Xiao-Feng Le; Robert C Bast
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

2.  Interleukin-1 deficiency prolongs ovarian lifespan in mice.

Authors:  Shiri Uri-Belapolsky; Aviv Shaish; Efrat Eliyahu; Hadas Grossman; Mattan Levi; Dana Chuderland; Lihi Ninio-Many; Noa Hasky; David Shashar; Tal Almog; Michal Kandel-Kfir; Dror Harats; Ruth Shalgi; Yehuda Kamari
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

Review 3.  Protein tyrosine kinase signaling during oocyte maturation and fertilization.

Authors:  Lynda K McGinnis; David J Carroll; William H Kinsey
Journal:  Mol Reprod Dev       Date:  2011-06-16       Impact factor: 2.609

Review 4.  The spatial and mechanical challenges of female meiosis.

Authors:  Janice P Evans; Douglas N Robinson
Journal:  Mol Reprod Dev       Date:  2011-07-19       Impact factor: 2.609

Review 5.  SRC-family tyrosine kinases in oogenesis, oocyte maturation and fertilization: an evolutionary perspective.

Authors:  William H Kinsey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Post-ovulatory aging of oocytes disrupts kinase signaling pathways and lysosome biogenesis.

Authors:  Lynda K McGinnis; Steven Pelech; William H Kinsey
Journal:  Mol Reprod Dev       Date:  2014-09-19       Impact factor: 2.609

7.  Fyn and argonaute 2 participate in maternal-mRNA degradation during mouse oocyte maturation.

Authors:  Natalie Gindi; Hadas Grossman; Hadas Bar-Joseph; Irit Miller; Luba Nemerovsky; Ron Hadas; Nava Nevo; Dalia Galiani; Nava Dekel; Ruth Shalgi
Journal:  Cell Cycle       Date:  2022-02-01       Impact factor: 5.173

8.  Regulation of GVBD in mouse oocytes by miR-125a-3p and Fyn kinase through modulation of actin filaments.

Authors:  Hadas Grossman; Efrat Har-Paz; Natalie Gindi; Mattan Levi; Irit Miller; Nava Nevo; Dalia Galiani; Nava Dekel; Ruth Shalgi
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

9.  The role of RING box protein 1 in mouse oocyte meiotic maturation.

Authors:  Lin Zhou; Ye Yang; Juanjuan Zhang; Xuejiang Guo; Ye Bi; Xin Li; Ping Zhang; Junqiang Zhang; Min Lin; Zuomin Zhou; Rong Shen; Xirong Guo; Ran Huo; Xiufeng Ling; Jiahao Sha
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

10.  Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.

Authors:  Melissa M Singh; Adrienne Howard; Mary E Irwin; Yin Gao; Xiaolin Lu; Asha Multani; Joya Chandra
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.